Want to join the conversation?
Specialty pharmacy care provider $ESRX said it expects to achieve adjusted diluted EPS of $6.08-6.28 in 2016, up 10-14% over the midpoint of the previously issued 2015 guidance range. $ESRX also reaffirms its previous 2015 adjusted diluted EPS guidance, representing growth of 13-14% over 2014 and all other previous 2015 financial guidance.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.